Definition of Binimetinib. Meaning of Binimetinib. Synonyms of Binimetinib

Here you will find one or more explanations in English for the word Binimetinib. Also in the bottom left of the page several parts of wikipedia pages related to the word Binimetinib and, of course, Binimetinib synonyms and on the right images related to the word Binimetinib.

Definition of Binimetinib

No result for Binimetinib. Showing similar results...

Meaning of Binimetinib from wikipedia

- Binimetinib, sold under the brand name M****vi, is an anti-cancer medication used to treat various cancers. Binimetinib is a selective inhibitor of MEK...
- BioPharma. In June 2018, it was approved by the FDA in combination with binimetinib for the treatment of people with unresectable or metastatic BRAF V600E...
- especially BRAF-mutated melanoma, and KRAS/BRAF mutated colorectal cancer. Binimetinib (MEK162), approved by the FDA in June 2018 in combination with encorafenib...
- the combination of a BRAF inhibitor encorafenib and a MEK inhibitor binimetinib for the treatment of un-resectable or metastatic melanoma with a BRAF...
- both as a monotherapy and in combination with other agents, such as binimetinib and crizotinib. Cao L, Chen S, Sun R, Ashby CR, Wei L, Huang Z, et al...
- acquisition of two Phase III cancer-drug candidates; the MEK inhibitor binimetinib (MEK 162) and the BRAF inhibitor encorafenib (LGX818), for $85 million...
- vemurafenib. Some MEK inhibitors include cobimetinib, CI-1040, PD0325901, binimetinib (MEK162), selumetinib, and trametinib (GSK1120212) It has been found...
- Pfizer acquired the company for approximately $11 billion. M****VI (Binimetinib) - selective MEK inhibitor - Approved 2018, acquired by Pfizer TUKYSA...
- C, et al. (2014). "A phase 1b/2 study of LEE011 in combination with binimetinib (MEK162) in patients with NRAS-mutant melanoma: Early encouraging clinical...
- Filgotinib Lestaurtinib Momelotinib Pacritinib Ruxolitinib MAP2K (MEK) Binimetinib Cobimetinib Mirdametinib Selumetinib Trametinib EML4-ALK Crizotinib Entrectinib...